FDA Amends Biologics Regulations to Remove Outdated Requirements and Increase Flexibility

Summary

The US Food and Drug Administration (FDA) is amending its biologics regulations to remove outdated inspection requirements and inspector duties, aiming to provide flexibility without compromising public health protections, as part of its efforts to streamline regulations and reduce burdens.